Hello new staff #13

Ames has worked at Lund university as research coordinator for 5 years. He is looking forward to being a part of KI. Ames brings a wealth of experience in administration and a has a strong passion for higher education. His goal is to support and enhance KI:s mission and vision by working closely with the Laboratory medicine divisions to improve the overall student experience.

Ana comes from Macedonia and did her Master in Molecular Medicine at the Norwegian University of Science and Technology (NTNU). For her master thesis she was looking at the development of the hippocampal formation in a NEIL3 knockout mouse model.  After finishing her master, she started working as a lab technician in Myriam Aouadi´s lab here at KI where she worked for 2 years.

For her PhD project in Uwe Tietge's group she will be looking at the role of HDL function in cardiometabolic disease.

Ping is a computational biologist. She received her PhD degree from University of Helsinki, Finland, where she developed several computational methods to study alternative splicing dynamics in mammalian evolution and treatment resistance in cancer. She continued her postdoc research training in the Integrated Cardiometabolic Center and Center for Infectious Medicine at KI, where she worked on single-cell data analysis of human metabolic tissues. Since 2021, she has been Assistant Professor and is currently setting up her independent research group in the Division of Clinical Chemistry at KI LABMED, focusing on data-driven research in human cardiometabolic diseases.

Nasrin obtained three Master's degrees: one in Biochemistry from Uppsala University in Sweden and the other Master's degree in Biotechnology and Business Administration (MBA) from the United States. She returned to Karolinska Institutet after working in academia and industry for over two decades in the United States. She has now joined Professor Mielke's group as a Laboratory Manager with responsibilities to support, coordinate, and facilitate the group members on their research projects, administrative tasks, and financial overviews within the cell- and gene therapy team.

Dr. Mohammad Razavi has a combined background in computer science and medical informatics, earning his PhD from University of Gothenburg. His research focused on discovering mobile antibiotic resistance genes in various environments. Currently, his work centers around predicting drug-resistant TB, researching resistance to new antibiotics and creating surveillance systems for detecting outbreaks.